Patents by Inventor Paul Noel Holvoet

Paul Noel Holvoet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 7579159
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: May 11, 2007
    Date of Patent: August 25, 2009
    Inventors: Paul Noel Holvoet, Désiré José Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 7390627
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: June 12, 2007
    Date of Patent: June 24, 2008
    Assignee: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Désiré José Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 7378250
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: May 27, 2008
    Assignee: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Desire Jose Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 7229776
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: June 12, 2007
    Assignee: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Désiré José Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 7229775
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: March 17, 2004
    Date of Patent: June 12, 2007
    Assignee: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Désiré José Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Publication number: 20040175759
    Abstract: Immunoassays for malondialdehyde-modified low density lipoprotein (MDA-modified LDL) and oxidized low density lipoprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Application
    Filed: March 17, 2004
    Publication date: September 9, 2004
    Applicant: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Desire Jose Collen
  • Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
    Patent number: 6727102
    Abstract: Immunoassays for malondialdehyde-modified low density lipprotein (MDA-modified LDL) and oxidized low density lipprotein (OxLDL), monoclonal antibodies (and the cell lines for them) for use in the assays, and a storage-stable standard (which may be used as a calibrator and/or control) are disclosed. MDA-modified LDL and OxLDL are implicated in atherosclerosis and its etiology.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: April 27, 2004
    Assignee: Leuven Research & Development VZW
    Inventors: Paul Noel Holvoet, Désiré José Collen